Evidence map›Paper›PMID 37589027›Full record

ArticlePhenomics (Cham, Switzerland)2023

Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy Adults.

Zhenghu Jia, Zhiyao Ren, Dongmei Ye, Jiawei Li, Yan Xu, Hui Liu, Ziyu Meng, Chengmao Yang, Xiaqi Chen, Xinru Mao and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Phenomics (Cham, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 1 country.

Zhenghu JiaGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Zhiyao RenDepartment of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, 510632 Guangdong China.
Dongmei YeOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 Guangdong China.
Jiawei LiGuangzhou Purui Biotechnology Co., Ltd., Guangzhou, 510660 Guangdong China.
Yan XuGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Hui LiuEmergency Department, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510632 Guangdong China.
Ziyu MengNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital, Tianjin Medical University, Tianjin, 300134 China.
Chengmao YangGuangzhou Purui Biotechnology Co., Ltd., Guangzhou, 510660 Guangdong China.
Xiaqi ChenZhongke Regenerative Medicine Technology Co., Ltd, Dongguan, 523808 Guangdong China.
Xinru MaoWuhan Purui Medical Laboratory Co., Ltd, Wuhan, 430223 Hubei China.
Xueli LuoWuhan Purui Medical Laboratory Co., Ltd, Wuhan, 430223 Hubei China.
Zhe YangGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Lina MaGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Anyi DengGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Yafang LiGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Bingyu HanGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Junping WeiGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Chongcheng HuangGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Zheng XiangGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.
Guobing ChenDepartment of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, 510632 Guangdong China.
Peiling LiOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 Guangdong China.
Juan OuyangWuhan Purui Medical Laboratory Co., Ltd, Wuhan, 430223 Hubei China.
Peisong ChenDepartment of Clinical Laboratory, Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080 Guangdong China.ORCID 0000-0003-0640-3663
Oscar Junhong LuoDepartment of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, 510632 Guangdong China.ORCID 0000-0002-1266-3069
Yifang GaoOrgan Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 Guangdong China.ORCID 0000-0003-2817-9391
Zhinan YinGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 519000 Guangdong China.ORCID 0000-0001-6524-8777
Jinan University · CNSun Yat-sen University · CNWuhan Puai Hospital · CNBeike Biotechnology (China) · CNFirst Affiliated Hospital of Jinan University · CNTianjin Infectious Diseases Hospital · CNXTC (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ageing is often accompanied with a decline in immune system function, resulting in immune ageing. Numerous studies have focussed on the changes in different lymphocyte subsets in diseases and immunosenescence. The change in immune phenotype is a key indication of the diseased or healthy status. However, the changes in lymphocyte number and phenotype brought about by ageing have not been comprehensively analysed. Here, we analysed T and natural killer (NK) cell subsets, the phenotype and cell differentiation states in 43,096 healthy individuals, aged 20-88 years, without known diseases. Thirty-six immune parameters were analysed and the reference ranges of these subsets were established in different age groups divided into 5-year intervals. The data were subjected to random forest machine learning for immune-ageing modelling and confirmed using the neural network analysis. Our initial analysis and machine modelling prediction showed that naïve T cells decreased with ageing, whereas central memory T cells (Tcm) and effector memory T cells (Tem) increased cluster of differentiation (CD) 28-associated T cells. This is the largest study to investigate the correlation between age and immune cell function in a Chinese population, and provides insightful differences, suggesting that healthy adults might be considerably influenced by age and sex. The age of a person's immune system might be different from their chronological age. Our immune-ageing modelling study is one of the largest studies to provide insights into 'immune-age' rather than 'biological-age'. Through machine learning, we identified immune factors influencing the most through ageing and built a model for immune-ageing prediction. Our research not only reveals the impact of age on immune parameter differences within the Chinese population, but also provides new insights for monitoring and preventing some diseases in clinical practice. Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-023-00106-0.

Indexed as

Immune-ageing modellingImmunosenescenceNatural killer cell subsetsPhenotypeT cell subset

Identifiers

PMID37589027
PMCPMC10425318
OpenAlexW4378085510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.